目錄:北京博蕾德科技發(fā)展有限公司>>Biomedica Gruppe>>心血管疾病>> Endostain ELISA Kit
Endostain檢測試劑盒
定量檢測人血清中Endostain
貨號(hào)：BI-20742
Endostain 是血管生成抑制劑
應(yīng)用領(lǐng)域：
1）微血管損傷
2）慢性腎?。?/span>CKD）
3) 局部貧血
產(chǎn)品優(yōu)勢：
試劑盒特點(diǎn)：
檢測方法：夾心ELISA，96孔，HRP/TMB顯色
樣本類型：血清、血漿（檸檬酸鹽抗凝、EDTA抗凝、肝素抗凝）、尿（參照對應(yīng)的protocol）
樣品量：5ul
標(biāo)準(zhǔn)品范圍：0-80 nmol/L(0-1600ng/ml)
檢測靈敏度：0.02nmol/L(0+3SD)
孵育條件：2h/1h/30min，室溫
單位轉(zhuǎn)換：1 ng/ml = 0.05 nmol/l (MW = 20 kDa)
特異性：只與人樣本反應(yīng)與其他種屬無交叉反應(yīng)
參考文獻(xiàn) |
Elevated plasma levels of endostatin are associated with chronic kidney disease. J Chen, LL Hamm, et al.Am J Nephrol, Jan 2012; 35(4): 335-340 |
Early-onset coronary artery disease after pediatric kidney transplantation: implicatingthe angiogenesi inhibitor, endostatin. CW Iqbal,et al. Am Surg, Jun 2011; 77(6): 731-735 |
Immobilized kidney 28-kDa endostatin-related (KES28kDa) fragment promotes endothelial cell survival.MH Bellini, et al. Am J Nephrol, Jan 2010; 31(3): 255-261 |
Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Neel R. Sodha, et al.Am J Physiol Heart Circ Physiol, Feb 2009; 296: H428-H434 |
A defective angiogenesis in chronic kidney disease.N Futrakul,et al. Jan 2008; 30(2): 215-217 |
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
會(huì)員.png)
12
化工儀器網(wǎng)